(Q30585383)

English

A randomized, double-blind evaluation of D-cycloserine or alprazolam combined with virtual reality exposure therapy for posttraumatic stress disorder in Iraq and Afghanistan War veterans

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

19 October 2017

A randomized, double-blind evaluation of D-cycloserine or alprazolam combined with virtual reality exposure therapy for posttraumatic stress disorder in Iraq and Afghanistan War veterans (English)

1 reference

Europe PubMed Central

19 October 2017

0 references

virtual reality

1 reference

based on heuristic

inferred from title

0 references

exposure therapy

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Kerry J. Ressler

11

1 reference

Europe PubMed Central

25 June 2017

Boadie W Dunlop

object named as

Boadie Dunlop

6

0 references

8

object named as

Bekh Bradley

1 reference

Europe PubMed Central

19 October 2017

Tanja Jovanovic

3

object named as

Tanja Jovanovic

1 reference

Europe PubMed Central

19 October 2017

Seth D Norrholm

4

object named as

Seth D Norrholm

1 reference

Europe PubMed Central

19 October 2017

Maryrose Gerardi

5

object named as

Maryrose Gerardi

1 reference

Europe PubMed Central

19 October 2017

9

object named as

Erica J Duncan

1 reference

Europe PubMed Central

19 October 2017

10

object named as

Albert Rizzo

1 reference

Europe PubMed Central

19 October 2017

Barbara Rothbaum

1

object named as

Barbara Olasov Rothbaum

1 reference

Europe PubMed Central

19 October 2017

author name string

Matthew Price

2

1 reference

Europe PubMed Central

19 October 2017

Michael Davis

7

1 reference

Europe PubMed Central

19 October 2017

language of work or name

0 references

publication date

1 June 2014

1 reference

Europe PubMed Central

19 October 2017

American Journal of Psychiatry

1 reference

Europe PubMed Central

19 October 2017

171

1 reference

Europe PubMed Central

19 October 2017

6

1 reference

Europe PubMed Central

19 October 2017

640-648

1 reference

Europe PubMed Central

19 October 2017

D-cycloserine augmentation of exposure therapy for post-traumatic stress disorder: a pilot randomized clinical trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4115813

20 June 2018

Pretreatment cortisol levels predict posttreatment outcomes among older adults with depression in cognitive behavioral therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4115813

20 June 2018

D-cycloserine enhancement of exposure therapy for social anxiety disorder depends on the success of exposure sessions

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4115813

20 June 2018

D-Cycloserine as an augmentation strategy with cognitive-behavioral therapy for social anxiety disorder

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4115813

20 June 2018

D-cycloserine enhancement of fear extinction is specific to successful exposure sessions: evidence from the treatment of height phobia.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4115813

20 June 2018

Fear extinction in traumatized civilians with posttraumatic stress disorder: relation to symptom severity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4115813

20 June 2018

Virtual reality exposure therapy for post-traumatic stress disorder and other anxiety disorders

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4115813

20 June 2018

Virtual reality exposure therapy for active duty soldiers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4115813

20 June 2018

Virtual reality exposure therapy using a virtual Iraq: case report

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4115813

20 June 2018

Augmentation of behavior therapy with D-cycloserine for obsessive-compulsive disorder

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4115813

20 June 2018

D-cycloserine augmented exposure therapy for obsessive-compulsive disorder

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4115813

20 June 2018

Alterations in stress reactivity after long-term treatment with paroxetine in women with posttraumatic stress disorder

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4115813

20 June 2018

Cognitive enhancers as adjuncts to psychotherapy: use of D-cycloserine in phobic individuals to facilitate extinction of fear

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4115813

20 June 2018

Combat duty in Iraq and Afghanistan, mental health problems, and barriers to care

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4115813

20 June 2018

Psychophysiological assessment: clinical applications for PTSD.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4115813

20 June 2018

The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4115813

20 June 2018

The development of a Clinician-Administered PTSD Scale

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4115813

20 June 2018

State-dependent fear extinction with two benzodiazepine tranquilizers.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4115813

20 June 2018

Effectiveness of national implementation of prolonged exposure therapy in Veterans Affairs care

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4115813

26 November 2018

Patient and facility characteristics associated with benzodiazepine prescribing for veterans with PTSD.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4115813

26 November 2018

Valproic acid but not D-cycloserine facilitates sleep-dependent offline learning of extinction and habituation of conditioned fear in humans

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4115813

26 November 2018

A randomized placebo-controlled trial of D-cycloserine and exposure therapy for posttraumatic stress disorder.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4115813

26 November 2018

Need for speed: evaluating slopes of OCD recovery in behavior therapy enhanced with d-cycloserine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4115813

26 November 2018

Efficacy of d-cycloserine for enhancing response to cognitive-behavior therapy for panic disorder

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4115813

26 November 2018

A randomized controlled trial of D-cycloserine enhancement of exposure therapy for social anxiety disorder

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4115813

26 November 2018

A randomized controlled trial of the effect of D-cycloserine on extinction and fear conditioning in humans.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4115813

26 November 2018

D-cycloserine and the facilitation of extinction of conditioned fear: consequences for reinstatement

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4115813

26 November 2018

Facilitation of conditioned fear extinction by systemic administration or intra-amygdala infusions of D-cycloserine as assessed with fear-potentiated startle in rats.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4115813

26 November 2018

A randomized placebo-controlled trial of D-cycloserine to enhance exposure therapy for posttraumatic stress disorder

1 reference

https://pubmed.ncbi.nlm.nih.gov/24743802

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1176/APPI.AJP.2014.13121625

1 reference

Europe PubMed Central

19 October 2017

1 reference

Europe PubMed Central

19 October 2017

1 reference

Europe PubMed Central

19 October 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q30585383&oldid=1971986426"